Search results
Mar 13, 2023 · Complementary and Alternative Medicine Market expected to reach USD 362.97 Bn by 2029 at a growth rate of 17.9 percent. MAXIMIZE MARKET RESEARCH PRIVATE LIMITED. Updated Mon, Mar 13, 2023, 8:07...
- 17.9 percent (2022-2029)
- USD 97.22 Bn
- 2022-2029
- USD 362.97 Bn
The global Complementary and Alternative Medicine Market Size was valued at $102 billion in 2021, and is projected to reach $437.9 billion by 2031, growing at a CAGR of 15.6% from 2022 to 2031.
Jul 31, 2023 · Europe emerged as the most significant global complementary and alternative medicine market, with a 26.72% market revenue share in 2022.
- Alternative Therapy Stocks to Buy: Cresco Labs
- Green Thumb Industries
- Alternative Therapy Stocks to Buy: Columbia Care
- Mind Medicine
- Alternative Therapy Stocks to Buy: Compass Pathways
- Havn Life Sciences
- Alternative Therapy Stocks to Buy: Neuronetics
Although claims of its medicinal benefits, particularly in the realm of mental health, are controversial, cannabis also remains one of the more promising alternative therapies. For instance, Psychiatric Times states that “many patients with psychiatric disorders use cannabis and report improvement in their symptoms. Patients use cannabis for sympto...
In addition to alleviating symptoms associated with mental health concerns, cannabis offers a pick-me-up, particularly for those suffering from serious difficulties. Psychiatric Timesstates that patients “use cannabis to reduce the nausea and anorexia of cancer chemotherapies and to improve their mood and outlook-frequently with their oncologist’s ...
One of the newer stocks to buy in the sector — well, at least new to me — Columbia Care features a portfolio of high-quality cannabis products, along with a national network of patient-oriented dispensaries. While many botanical firms are geared toward the therapeutic benefit angle, in my view, Columbia Care takes it to the next level. For instance...
For Mind Medicine, I’m going to get my personal bias out of the way. For one thing, I was the first person at InvestorPlace to direct readers to this opportunity(back then, the company had the ticker symbol “MMEDF”). Second, while an incredibly speculative new issue, I decided to take a gamble with my own money. To loosely paraphrase one the many i...
A mental healthcare firm focused on delivering patient access to evidence-based innovation in mental health treatments and solutions, Compass Pathways specializes in psilocybin therapy. According to Compass’ website, “Psilocybin therapy is an approach being investigated for the treatment of mental health challenges. It combines the pharmacological ...
One of the riskiest stocks to buy no matter what the industry, as of the start of August 2, the price for Canada-based HAVN Life Sciences shares is 34 cents. On a YTD basis, HAVLF stock is down more than 55%. In some cases, speculators might look at such a downfall as a buy-the-dips moment. However, there has to be a point when a discount is too st...
While the vast majority of stocks to buy on this list focused on cannabis or psychedelic-based approaches for addressing mental health issues, not every alternative therapy in this space has to involve controversial compounds. Instead, alternative could mean companies like Neuronetics, a medical device company that helps improve quality of life for...
- Josh Enomoto
U.S. Complementary And Alternative Medicine Market Size, Share & Trends Analysis Report By Intervention (Traditional Alternative Medicine/Botanicals, Mind Healing), By Distribution (Direct Sales, E-sales) By Region, And Segment Forecasts, 2024 - 2030
Aug 16, 2024 · The U.S. complementary and alternative medicine market size is anticipated to reach USD 124.2 billion by 2030, growing at a CAGR of 23.9% from 2024 to 2030. The increasing prevalence of...
People also ask
How much is the complementary and alternative medicine market worth?
What is the Global Complementary and alternative medicine market size?
What is the value of complementary and alternative medicine in 2021?
What is supplementary and alternative medicine market analysis?
Data Bridge Market Research analyses that the complementary and alternative medicine market was valued at USD 100.04 billion in 2021 and is expected to reach USD 477.29 billion by 2029, registering a CAGR of 21.57% during the forecast period of 2022 to 2029.
